Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage
Evaluation of the Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage: A Randomized Controlled Trial
Sponsor: Denver Health and Hospital Authority
This NA trial investigates Postpartum Hemorrhage, Immediate and is currently ongoing. Denver Health and Hospital Authority leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting NA
Status: Unknown → Active Not Recruiting
-
Jan 2025 — Dec 2025 [monthly]
Unknown NA
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Enrolling By Invitation NA
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
-
Jan 2023 — Jul 2024 [monthly]
Enrolling By Invitation NA
▶ Show 4 earlier versions
-
Dec 2021 — Jan 2023 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation NA
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Aug 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Denver Health and Hospital Authority
For direct contact, visit the study record on ClinicalTrials.gov .